0000899243-19-025205.txt : 20191007 0000899243-19-025205.hdr.sgml : 20191007 20191007195303 ACCESSION NUMBER: 0000899243-19-025205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191007 DATE AS OF CHANGE: 20191007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HealthCap VII, L.P. CENTRAL INDEX KEY: 0001645161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 191141710 BUSINESS ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1000-1018 BUSINESS PHONE: 41 21 614 3500 MAIL ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1000-1018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HealthCap VII GP S.A. CENTRAL INDEX KEY: 0001790047 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 191141711 BUSINESS ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1006 BUSINESS PHONE: 41-21-614 35 00 MAIL ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1006 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-07 0 0001781983 Aprea Therapeutics, Inc. APRE 0001645161 HealthCap VII, L.P. C/O HEALTHCAP VII GP S.A. 18 AVENUE OF D'OUCHY LAUSANNE V8 CH-1006 SWITZERLAND 0 0 1 0 0001790047 HealthCap VII GP S.A. C/O HEALTHCAP VII GP S.A., 18 AVENUE OF D'OUCHY LAUSANNE V8 CH-1006 SWITZERLAND 0 0 1 0 Common Stock 2019-10-07 4 C 0 1661382 A 1671941 I See footnote Common Stock 2019-10-07 4 C 0 427496 A 2099437 I See footnote Common Stock 2019-10-07 4 P 0 266667 15.00 A 2366104 I See footnote Series B Convertible Preferred Stock 2019-10-07 4 C 0 1661382 D Common Stock 1661382 0 I See footnote Series C Convertible Preferred Stock 2019-10-07 4 C 0 427496 D Common Stock 427496 0 I See footnote Immediately prior the closing of the Issuer's initial public offering the shares of preferred stock automatically converted into shares of the common stock. Each share of preferred stock was convertible into shares of common stock at any time at the option of the holder and had no expiration date. The securities are directly held by HealthCap VII L.P. (the "Fund"). HealthCap VII GP S.A. (the "General Partner") is the sole general partner of the Fund. The General Partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. /s/ HealthCap VII L.P., By: Louis Rambo, attorney-in-fact 2019-10-07 /s/ HealthCap VII GP S.A., By: Louis Rambo, attorney-in-fact 2019-10-07